CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):: US15870P3073
LEI:: 549300O8WKLP8QEG5U47
Country:: United States of America
Address:: 855 N. WOLFE STREET, 21205 BALTIMORE
Website:: https://championsoncology.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Model Solution Co., Ltd. One-stop prototyping & low-volume production for IT, electronics, and medical hardware.	South Korea	417970
Modus Therapeutics Holding AB Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.	Sweden	MODTX
Moleculin Biotech, Inc. Developing therapies for hard-to-treat tumors (like AML) and viruses.	United States of America	MBRX
Molecure S.A. Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.	Poland	MOC
Moolec Science SA Uses Molecular Farming to grow animal proteins in plants for food, feed, and supplement industries.	United States of America	MLEC
MoonLake Immunotherapeutics Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.	United States of America	MLTX
Mural Oncology plc Developing cytokine-based immunotherapies for difficult-to-treat cancers and solid tumors.	United States of America	MURA
Mural Oncology PLC Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.	Ireland	MURA
N2OFF, Inc. Sustainable agri-tech for food preservation, emissions reduction, and renewable energy.	United States of America	NITO
NANO MRNA Co.,Ltd. Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.	Japan	4571